BioCryst Pharmaceuticals Revenue 2006-2020 | BCRX

BioCryst Pharmaceuticals revenue from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
BioCryst Pharmaceuticals Annual Revenue
(Millions of US $)
2019 $49
2018 $21
2017 $25
2016 $26
2015 $48
2014 $14
2013 $17
2012 $26
2011 $20
2010 $62
2009 $75
2008 $57
2007 $71
2006 $6
2005 $0
BioCryst Pharmaceuticals Quarterly Revenue
(Millions of US $)
2020-06-30 $3
2020-03-31 $5
2019-12-31 $40
2019-09-30 $2
2019-06-30 $1
2019-03-31 $6
2018-12-31 $3
2018-09-30 $1
2018-06-30 $12
2018-03-31 $4
2017-12-31 $4
2017-09-30 $9
2017-06-30 $3
2017-03-31 $9
2016-12-31 $9
2016-09-30 $8
2016-06-30 $5
2016-03-31 $5
2015-12-31 $5
2015-09-30 $11
2015-06-30 $26
2015-03-31 $7
2014-12-31 $5
2014-09-30 $3
2014-06-30 $1
2014-03-31 $3
2013-12-31 $11
2013-09-30 $2
2013-06-30 $1
2013-03-31 $4
2012-12-31 $4
2012-09-30 $6
2012-06-30 $4
2012-03-31 $12
2011-12-31 $5
2011-09-30 $5
2011-06-30 $4
2011-03-31 $5
2010-12-31 $17
2010-09-30 $12
2010-06-30 $8
2010-03-31 $26
2009-12-31 $55
2009-09-30 $11
2009-06-30 $5
2009-03-31 $4
2008-12-31 $34
2008-09-30 $9
2008-06-30 $3
2008-03-31 $11
2007-12-31 $28
2007-09-30 $20
2007-06-30 $13
2007-03-31 $9
2006-12-31 $2
2006-09-30 $2
2006-06-30 $2
2006-03-31 $1
2005-12-31 $0
2005-09-30 $0
2005-06-30 $0
2005-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.618B $0.049B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.705B 43.06
Takeda Pharmaceutical (TAK) Japan $58.641B 10.22
Astellas Pharma (ALPMY) Japan $28.560B 14.47
Eisai (ESALY) Japan $26.741B 22.60
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.902B 24.79
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.802B 44.87
Grifols, S.A (GRFS) Spain $11.173B 13.65
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.267B 35.87
IPSEN SA ADR (IPSEY) France $8.673B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.657B 12.67
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.891B 43.65
Arrowhead Pharmaceuticals (ARWR) United States $4.566B 0.00
United Therapeutics (UTHR) United States $4.466B 10.32
Evotec AG (EVTCY) Germany $4.033B 140.00
FibroGen (FGEN) United States $3.976B 0.00
ChemoCentryx (CCXI) United States $3.511B 0.00
Nektar Therapeutics (NKTR) United States $3.383B 0.00
Hypermarcas (HYPMY) Brazil $3.326B 12.23
Sage Therapeutics (SAGE) United States $3.118B 0.00
PTC Therapeutics (PTCT) United States $3.074B 0.00
Pacira BioSciences (PCRX) United States $2.519B 66.22
Xencor (XNCR) United States $2.157B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.123B 10.28
Revolution Medicines (RVMD) United States $2.109B 0.00
Corcept Therapeutics (CORT) United States $1.971B 18.15
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.780B 0.00
Cronos Group (CRON) Canada $1.767B 0.00
USANA Health Sciences (USNA) United States $1.563B 14.73
Ironwood Pharmaceuticals (IRWD) United States $1.515B 10.52
Trillium Therapeutics (TRIL) Canada $1.371B 0.00
Heron Therapeutics (HRTX) United States $1.345B 0.00
Indivior (INVVY) United States $1.218B 15.09
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.202B 11.46
Karyopharm Therapeutics (KPTI) United States $1.095B 0.00
Zogenix (ZGNX) United States $1.036B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.032B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Esperion Therapeutics (ESPR) United States $0.983B 0.00
Translate Bio (TBIO) United States $0.923B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.870B 542.00
VAXART, INC (VXRT) United States $0.785B 0.00
Endo (ENDP) Ireland $0.704B 1.04
Spectrum Pharmaceuticals (SPPI) United States $0.644B 0.00
ImmunoGen (IMGN) United States $0.631B 0.00
Collegium Pharmaceutical (COLL) United States $0.618B 0.00
Tilray (TLRY) Canada $0.598B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.561B 0.00
Siga Technologies (SIGA) United States $0.552B 58.92
Aerie Pharmaceuticals (AERI) United States $0.541B 0.00
Radius Health (RDUS) United States $0.525B 0.00
Flexion Therapeutics (FLXN) United States $0.519B 0.00
Ocular Therapeutix (OCUL) United States $0.518B 0.00
Molecular Templates (MTEM) United States $0.499B 0.00
Ardelyx (ARDX) United States $0.495B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.448B 0.00
Altimmune (ALT) United States $0.412B 0.00
Harpoon Therapeutics (HARP) United States $0.399B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.395B 19.69
Rigel Pharmaceuticals (RIGL) United States $0.383B 0.00
Organogenesis Holdings (ORGO) United States $0.376B 0.00
TherapeuticsMD (TXMD) United States $0.370B 0.00
Redhill Biopharma (RDHL) Israel $0.366B 0.00
Akebia Therapeutics (AKBA) United States $0.364B 0.00
MEI Pharma (MEIP) United States $0.347B 0.00
DURECT (DRRX) United States $0.339B 0.00
Innate Pharma SA (IPHYF) France $0.324B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.322B 7.97
PROFOUND MEDICL (PROF) Canada $0.314B 0.00
IMV INC (IMV) Canada $0.309B 0.00
Concert Pharmaceuticals (CNCE) United States $0.291B 0.00
Xeris Pharmaceuticals (XERS) United States $0.277B 0.00
Jounce Therapeutics (JNCE) United States $0.271B 12.84
Aquestive Therapeutics (AQST) United States $0.270B 0.00
Menlo Therapeutics (VYNE) United States $0.255B 0.00
Rafael Holdings (RFL) United States $0.254B 0.00
Calithera Biosciences (CALA) United States $0.242B 0.00
KalVista Pharmaceuticals (KALV) United States $0.241B 0.00
Lannett Co Inc (LCI) United States $0.234B 5.43
Oasmia Pharmaceutical AB (OASMY) Sweden $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.214B 21.11
Avadel Pharmaceuticals (AVDL) Ireland $0.196B 0.00
CASI Pharmaceuticals (CASI) United States $0.188B 0.00
Heat Biologics (HTBX) United States $0.187B 0.00
Nivalis Therapeutics (ALPN) United States $0.186B 0.00
OptiNose (OPTN) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
Otonomy (OTIC) United States $0.164B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.158B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.138B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.123B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.110B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.109B 0.00
MediWound (MDWD) Israel $0.101B 0.00
Aclaris Therapeutics (ACRS) United States $0.101B 0.00
Lipocine (LPCN) United States $0.094B 0.00
Hemispherx BioPharma (AIM) United States $0.090B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
CTI BioPharma (CTIC) United States $0.077B 0.00
Biomerica (BMRA) United States $0.077B 0.00
ElectroCore (ECOR) United States $0.074B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.072B 0.00
Novan (NOVN) United States $0.072B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.068B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.064B 0.00
Infinity Pharmaceuticals (INFI) United States $0.064B 0.00
Addex Therapeutics (ADXN) Switzerland $0.063B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.055B 0.00
KemPharm (KMPH) United States $0.051B 0.00
CV Sciences (CVSI) United States $0.051B 0.00
Recro Pharma (REPH) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.45
SCYNEXIS (SCYX) United States $0.049B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
India Globalization Capital (IGC) United States $0.046B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.042B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
PolarityTE (PTE) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
IsoRay (ISR) United States $0.038B 0.00
GTx (ONCT) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.09
Opiant Pharmaceuticals (OPNT) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.031B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.031B 0.00
Neos Therapeutics (NEOS) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Sundial Growers (SNDL) Canada $0.022B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Vical (BBI) United States $0.022B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.016B 24.55
Flex Pharma (SLRX) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
JanOne (JAN) United States $0.009B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00